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Abstract
Phage display libraries have provided an extraordinarily versatile technology to facilitate the isolation of peptides, growth factors, single
chain antibodies, and enzymes with desired binding specificities or enzymatic activities. The overall diversity of peptides in phage display
libraries can be significantly limited by Escherichia coli protein folding and processing machinery, which result in sequence censorship. To
achieve an optimal diversity of displayed eukaryotic peptides, the library should be produced in the endoplasmic reticulum of eukaryotic
cells using a eukaryotic display platform. In the accompanying article, we presented experiments that demonstrate that polypeptides of
various sizes could be efficiently displayed on the envelope glycoproteins of a eukaryotic virus, avian leukosis virus (ALV), and the
displayed polypeptides could efficiently attach to cognate receptors without interfering with viral attachment and entry into susceptible cells.
In this study, methods were developed to construct a model library of randomized eight amino acid peptides using the ALV eukaryotic
display platform and screen the library for specific epitopes using immobilized antibodies. A virus library with approximately 2  106
different members was generated from a plasmid library of approximately 5  106 diversity. The sequences of the randomized 24
nucleotide/eight amino acid regions of representatives of the plasmid and virus libraries were analyzed. No significant sequence censorship
was observed in producing the virus display library from the plasmid library. Different populations of peptide epitopes were selected from
the virus library when different monoclonal antibodies were used as the target. The results of these two studies clearly demonstrate the
potential of ALV as a eukaryotic platform for the display and selection of eukaryotic polypeptides libraries.
© 2003 Elsevier Inc. All rights reserved.
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Introduction
Phage display technology, the display of libraries of
modularly coded polypeptides on filamentous bacteriophage
and screening them for specific properties, has provided a
versatile technology for the discovery and characterization
of protein–protein interactions (see reviews Bradbury, 1999,
2000; Li, 2000). Phage display libraries have been used to
select polypeptides that specifically bind to unique antigens
on immobilized proteins and to targeted receptors on cul-
tured cells (Li, 2000). More recently, several groups have
developed in vivo selection strategies of phage display
polypeptide libraries in mice (Johns et al., 2000; Pasqualini
and Ruoslahti, 1996; Rajotte et al., 1998; Rajotte and Ruo-
slahti, 1999). These selection strategies enable the study of
cells, organs, and tumors in their natural environment, a
complexity that is difficult to model in cultured cells. Sev-
eral peptides with specific binding properties identified by
phage display technology have been used to target thera-
peutic drugs to tumors (Arap et al., 1998; Ellerby et al.,
1999) and/or to alter the biodistribution of adenoviral gene
therapy vectors (Trepel et al., 2000).
While phage display technology has many advantages, it
also has limitations. The limitations of phage display are
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Fig. 1. Schematic representations of the construction and screening of the ALV 8-mer peptide display library. Construction: The plasmid encoding the
FXL(A) ALV virus was used to construct the plasmid library. The FXL(A) virus was constructed from the RCASBP(A)AP infectious molecular clone
containing the gag, pol, and env viral genes, and a heat-stable alkaline phosphatase (AP) reporter gene flanked by viral long-terminal repeats (LTRs). The
FXL(A) env gene encodes five nonviral epitopes in-frame at the N-terminus of SU: the eight amino acid FLAG epitope tag, the SfiI and NotI restriction
enzyme sites, the Factor Xa (Fxa) protease cleavage site, and a flexible linker consisting of glycine, glycine, glycine, glycine, and serine (G4S). The 24
nucleotides (N24) encoding the FLAG epitope in FXL(A) env were randomized by PCR; the amplified PCR fragments were subcloned into the unique
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mainly related to the restrictions imparted by Escherichia
coli on the expression, assembly, folding, transport, and
posttranslational modifications of the viral proteins and their
incorporation into viral particles (Jestin et al., 2001; Smith
and Petrenko, 1997; Wilson and Finlay, 1998). The host
biology restrictions result in a significant reduction in the
synthesis of viral proteins fused to nonviral polypeptides
due to differences in codon usage, a high frequency of
partial proteolysis and/or misfolding of the fusion protein,
and defects in the transport and/or incorporation of the
fusion proteins into viral particles. These restrictions can
significantly reduce the sequence diversity of the polypep-
tides actually displayed on viruses in a phage display library
(Rodi et al., 2002). In addition, bacteria do not have the
enzymatic machinery to posttranslationally modify proteins
(e.g., N-linked glycosylation), a characteristic of many eu-
karyotic proteins that can be important for folding, assem-
bly, solubility, and binding interactions. The development
of a viral polypeptide display platform capable of efficient
synthesis of eukaryotic polypeptides in eukaryotic cells and
display of the polypeptides on virions would expand the
versatility of display technology.
Retroviruses have characteristics that make them prom-
ising candidates to be a eukaryotic platform for the display
of eukaryotic polypeptides. Eukaryotic cells also have an
efficient quality control system that assesses whether a pro-
tein has been properly folded and modified, including ret-
roviral glycoproteins, before transport to the cell surface and
incorporation into virions (reviewed in Braakman and van
Anken, 2000; Chevet et al., 2001). The display of a variety
of nonviral polypeptides on the SU glycoprotein of a murine
retrovirus, murine leukemia virus (MLV), demonstrated that
a library of polypeptides could be display on a retrovirus,
and the library selected against eukaryotic cellular targets
(reviewed in Russell and Cosset, 1999). Since these initial
studies, characteristics that limit the usefulness of MLV as
a display platform have been found. The displayed polypep-
tides were found to be shed from MLV virions at a signif-
icant rate; certain displayed polypeptides could block MLV
infection of susceptible cells, and the infectivity of MLV
displaying SU-polypeptide fusions were significantly re-
duced compared to wild-type virus (Ager et al., 1996; Cos-
set et al., 1995; Nilson et al., 1996).
The characteristics of another retrovirus, the avian leu-
kosis virus (ALV), appeared to offer advantages over MLV
as a eukaryotic platform for the display of eukaryotic
polypeptides as SU fusion proteins. The displayed polypep-
tides will be maintained on ALV virions since little or no
SU is normally shed from ALV due to a covalent bond
between the SU and TM glycoproteins (Einfeld and Hunter,
1988). The ALV genome can also stably maintain up to 2.5
kb of additional sequence, providing ample room to encode
SU fusions displaying large nonviral polypeptides, and still
encode a replication-competent virus (Federspiel and
Hughes, 1997). In the accompanying study, we demon-
strated that polypeptides of various sizes could be efficiently
displayed as N-terminal SU fusions on ALV virions, and the
displayed polypeptide could efficiently attach to a cognate
receptor immobilized on a solid support or expressed on the
cell surface. The foreign polypeptides did not interfere with
the attachment and entry functions of the underlying ALV
envelope glycoproteins in virions, and the genes encoding
the chimeric glycoproteins were stably maintained through
multiple virus replication cycles. In this study, we tested
whether we could develop methods to construct a model
library of randomized peptides displayed on ALV, and
screen the library for specific epitopes using immobilized
antibodies.
Results and discussion
Virus enrichment was specific upon selection of a
displayed epitope with an immobilized antibody
The process of screening a peptide display library to
select rare peptides that bind a target depends on an efficient
selection protocol (Fig. 1). The protocol for screening an
ALV peptide display library was developed and optimized
by testing different selection conditions on the efficiency of
recovering a virus displaying a known peptide at different
concentrations (1–50% of the virus population) by an im-
mobilized antibody. Different ratios of the ALV-GFP virus
with no displayed peptide and the FXL(A) virus displaying
the FLAG tag peptide (DYKDDDDK) were selected in a
tissue culture dish coated with an immobilized anti-FLAG
monoclonal antibody. Bound viruses were recovered by
adding DF-1 cells to allow virus infection and amplification.
The optimal selection conditions produced a consistent
100-fold enrichment for the FXL(A) Flag displaying tar-
KpnI-NotI sites of FXL(A), and the resulting plasmids were transformed into E. coli to produce the 8-mer plasmid library (each different eight amino acid
peptide is represented by a different colored square). ALVs displaying the chimeric envelope glycoproteins were produced by transfecting plasmid library
DNA containing the infectious molecular clones into chicken DF-1 cells (the different 8-mer peptides are represented as colored circles; the two strands of
viral genomic RNA are represented by colored rectangles). Since the DNA transfection procedure results in the entry of multiple plasmids into a cell, and
each plasmid encodes a different peptide, each transfected cell will express many different chimeric glycoproteins that can be incorporated into viral particles
that will not be encoded by the encapsidated viral genomic RNA. Therefore, the initial production of recombinant viruses results in an Unlinked Virus Library,
i.e., the chimeric glycoproteins expressed on the virion surface are not encoded by the viral RNA. Fresh DF-1 cells were infected with the Unlinked Virus
Library at a low multiplicity of infection (m.o.i.) to link the displayed glycoprotein phenotype with the packaged genotype in each virus of the Virus Library.
Selection: A target antibody (Y) is coated onto a solid support, treated to reduce nonspecific virus binding, and incubated with the ALV peptide display
library. After washing to remove unbound viruses, DF-1 chicken cells are added to amplify the bound viruses. The selection strategy can be repeated to select
dominant peptides that bind a protein target.
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get virus (Table 1), a level and specificity of enrichment that
should allow the selection of rare binding peptides after
several rounds of screening.
Overview of the experimental approach for constructing
an ALV peptide display library
In the accompanying article, we demonstrated that bio-
logically active polypeptides of different sizes could be
efficiently displayed on ALV virions as N-terminal exten-
sions of the SU glycoprotein without altering ALV entry
and replication. To test whether ALV could be a platform
for the display of a library of random peptides that are
linked to the viral genotype, a model ALV peptide display
library was constructed based on the ALV virus displaying
the FLAG epitope, FXL(A) (see accompanying article). The
organization of the nonviral epitopes fused to the N-termi-
nus of the FXL(A) SU glycoprotein and the major steps of
the ALV 8-mer peptide display library construction are
shown in Fig. 1.
Construction of the randomized plasmid library
The 24 nucleotides that encode the eight amino acid
FLAG epitope of FXL(A) plasmid were randomized by
synthesizing overlapping primers comprising random nucle-
otides in this region flanked by fixed nucleotide sequences.
This pool of 3-primers was used with a fixed 5-primer to
amplify the viral region encoding the signal peptide of the
N-terminus of env by PCR. The amplified fragments were
digested with KpnI and NotI and inserted into the
FCXL(A) plasmid containing the infectious molecular
clone. The ligated plasmids were transformed into bacteria
and grown under drug selection to amplify the plasmid
library. Since the plasmids containing the ALV molecular
clones do not transcribe or translate the ALV sequences in
bacteria, we do not expect the maintenance of certain plas-
mids to be under selective pressure and result in a bias of the
library. Therefore, the sequence diversity of the targeted
24-nucleotide region of the plasmids should be random in
the plasmid library.
A summary of the construction parameters of the ran-
domized plasmid library is shown in Table 2. The maximum
possible sequence diversity of the plasmid library is the
number of transformed bacterial colonies harvested, 5 
106. The nucleotide sequences of the plasmids contained in
176 individual colonies were determined to analyze the
actual sequence diversity of the 24-nucleotide randomized
region, and the diversity of the translated peptides, obtained
in the plasmid library. We estimate that the observed fre-
quency of each nucleotide in the randomized region of the
plasmid library reflects the synthesized primers used to
amplify the region. Using the observed sequences, several
sets of statistical analyses were used to test whether there
was any correlation of nucleotide with position in the 24-
mer sequence and whether there was any clustering of
certain combinations of nucleotides. These analyses suggest
a nonrandom mechanism such that the nucleotide selection
probabilities vary with position in the randomized sequence,
although there was no obvious pattern (data not shown).
While the process was not strictly random, the statistical
analyses did demonstrate great diversity in the pool of
plasmid sequences.
Construction of the ALV 8-mer randomized peptide
display library
ALV replication can be initiated by the transfection of
chicken DF-1 cells with plasmid DNA containing an infec-
tious molecular clone in a proviral form (Federspiel and
Hughes, 1997). To produce an ALV peptide display library,
the randomized plasmid library was transfected into DF-1
cells to produce infectious virus. However, the transfection
procedure often results in multiple plasmids entering each
transfected cell, and in this case each plasmid encodes a
viral glycoprotein that displays a different peptide. There-
fore, each transfected cell will contain many different viral
genomes and express multiple viral glycoproteins display-
ing different peptides on the cell surface. Since each infec-
tious ALV produced by these cells will have a variety of
glycoproteins displaying different peptides and two copies
of the viral genome that may not encode any of the dis-
played peptides, the displayed peptide phenotype is not
linked to the viral genotype. To link the phenotype with the
genotype in each virus, fresh DF-1 cells were infected with
a low level [0.1 multiplicity of infection (m.o.i)] of this
Table 1
The specificity of virus enrichment after one-round of selection with an
immobilized anti-Flag mAb and subsequent amplification in DF-1 cells
wt-GFP/Flag-AP
virus ratioa
Ratio of virus recovered
over virus input (100)
Fold
enrichmentd
wt-GFPb Flag-APc
1:1 0.28 38.3 137
5:1 0.21 85.1 405
10:1 0.30 106.4 355
50:1 0.23 50.5 220
100:1 0.38 149.4 393
No antibodye 0.14 0.15 1
a RCASBP(A) with a wild-type envelope glycoprotein and containing
the GFP reporter gene (wt-GFP) was mixed with different amounts of
FXL(A), the RCASBP(A) virus displaying the Flag epitope on the enve-
lope glycoproteins and containing the AP reporter gene (Flag-AP). The
virus mixture was incubated in wells coated with an anti-Flag mAb and
washed, and the bound virus amplified by adding DF-1 cells.
b The titers of the input and recovered wt-GFP virus were determined by
FACS.
c The titers of the input and recovered Flag-AP virus were determined by
AP assay.
d Determined by dividing the recovered/input ratios of Flag-AP with
wt-GFP.
e The wt/Flag virus ratio of 1:1 selected and amplified as above but
without the immobilized anti-Flag mAb.
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initial unlinked ALV peptide display library so that each
cell would be infected by only one virus. The subsequent
“deconvoluted” virus pool was amplified to produce the
now linked ALV 8-mer peptide display library. A summary
of the construction parameters of the model ALV 8-mer
peptide display library is shown in Table 2.
No evidence of sequence censorship was detected from
converting the plasmid library of ALV molecular clones
to a virus display library
One goal of these experiments was to determine if a
significant sequence censorship of the possible randomized
sequences would occur upon producing an ALV virus pep-
tide display library from the randomized plasmid library.
The generation of the ALV 8-mer peptide display library
resulted in some loss of sequence diversity of the random-
ized 24-nucleotide region from the randomized plasmid
library. Minimally, viral genomes that contain nonviral se-
quences that encode a termination codon are lost since
functional glycoproteins cannot be synthesized, resulting in
the production of noninfectious virus. Other nonviral pep-
tides that reduce the efficiency of glycoprotein processing
and/or transport might also be lost, resulting in a further
reduction in the actual diversity of the peptides displayed on
ALV in the virus library. At each step of the generation of
the virus display library, sufficient plasmid library DNA,
DF-1 cells, and/or viruses from the unlinked virus library
were used to maintain the maximum possible diversity that
could be provided by the plasmid library. In addition, the
unlinked virus library and the final linked virus library were
not amplified by multiple virus passages to minimize the
loss of peptide sequences that may slow viral replication.
To determine if significant sequence censorship had oc-
curred, the nucleotide sequences of the randomized regions
from 54 individual viral clones produced by RT-PCR am-
plification of ALV genomic RNA were determined and
compared to the nucleotide sequences from the plasmid
library. The overall nucleotide frequencies in the random-
ized sequences of the virus library were not significantly
different from the frequencies observed in the plasmid li-
brary (Table 2). In addition, the relative frequency of each
amino acid at each position in the 8-mer peptides encoded
by the plasmid library is statistically similar to the virus
library except for the frequency of the termination codons,
which were greatly reduced in the virus library (Fig. 2). We
conclude from these analyses that the overall sequence
diversity of the randomized region of the plasmid peptide
display library was maintained in the virus library without
detectable bias.
Different populations of peptides were selected from the
ALV 8-mer peptide display library with different target
antibodies
The optimal conditions for screening ALV were deter-
mined using a mixture of wild-type ALV and ALV display-
ing one type of peptide, FLAG (Table 1). These screening
conditions were then tested to determine if a particular ALV
displaying FLAG peptide, FXL(A), could be efficiently
selected from a complex mixture of peptide displaying vi-
ruses, the ALV 8-mer library. An aliquot of the ALV 8-mer
library was spiked with 1% FXL(A) virus and selected
with the anti-FLAG monoclonal antibody for three rounds.
Viral genomes from each selected population were ampli-
fied by RT-PCR and cloned, and the nucleotide sequence of
Table 2
Summary of the construction of the ALV 8-mer display library
Plasmid library construction PCR product with randomized 24-nucleotides 2 g
FXL(A) plasmid containing ALV molecular clone 18 g
Plasmid library characterization Number of plasmid colonies selected 5  106
Number of plasmids sequenced 176
Actual frequency of each nucleotide
● A 27%
● C 38%
● G 16.5%
● T 18.5%
Virus library construction Amount of DNA transfected 30 g
Total number of DF-1 cells transfected 9  106
Estimated transfection efficiency 60–75%
Unlinked virus library: total virus yield 1.2  107
Deconvolution of virus library Number of DF-1 cells 4  107
Amount of unlinked virus library (each virus likely has two different genomes) 4  106
Virus library characterization Total virus yield 1.85  109
Virus titer 1.85  106/ml
Number of viruses sequenced 54
Actual frequency of each nucleotide
● A 25%
● C 38%
● G 17%
● T 20%
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10–20 clones were determined. The majority of the viruses
recovered after each round of selection coded for the ex-
pected FLAG peptide from FXL(A), DYKDDDDK (Fig.
3A). However, despite the high concentration of the spiked
FXL(A) virus, other peptides homologous to the optimal
FLAG peptide were also selected, e.g., DYQDHDHK
(Round 1), DTRMTDDK (Round 2), and DYKDDDDM
(Round 3).
To further test the library screening conditions, the same
aliquot of the ALV 8-mer library spiked with FXL(A) was
screened for peptides that bind two other monoclonal anti-
bodies, an antiinfluenza hemaglutinnin antibody (anti-HA)
that recognizes the peptide YPYDVPDYA Fig. 3B), and an
antivesicular stomatitis virus (VSV) glycoprotein antibody
(anti-VSV glycoprotein) that recognizes the peptide NR-
LGK (Fig. 3C). A different dominant peptide was selected
from the virus library by each immobilized target antibody
after three rounds of screening, PPATYSSH by anti-HA,
and NCNTPFWA by anti-VSV glycoprotein. We believe
the screening was successful for both targets since it is not
unusual for peptides to be specifically selected using a
display technology that is different from the optimal peptide
recognized by the target antibody (Ferrieres et al., 2000;
Scott and Smith, 1990; Tighe et al., 1999). These results
demonstrate that the procedure for screening this ALV pep-
tide display library with an immobilized antibody is effi-
cient and selects peptides specific for that target.
Conclusions
In this study we demonstrate that ALV is indeed a useful
eukaryotic platform for the display of a randomized peptide
library of reasonable sequence diversity. We also have de-
veloped efficient screening procedures for the selection of
specific peptides that bind to immobilized target proteins.
We are now in the process of building a very large ALV
peptide display library (109 sequence diversity) that will
be used to isolate a variety of cell-targeting peptides.
Materials and methods
Plasmid library construction
The construction of the RCASBP(A)/AP retroviral vec-
tor, an ALV-based replication competent vector with a sub-
group A env gene (A), and the heat-stable human placental
alkaline phosphatase gene (AP), has been described (Fed-
erspiel and Hughes, 1997; Fekete and Cepko, 1993; Fields-
Berry et al., 1992). The plasmid FXL(A) is derived from
RCASBP(A)AP and contains five nonviral regions in-frame
at the N- terminus of SU (1): the 24 nucleotides FLAG
epitope (DYKDDDDK), two restriction endonuclease sites
SfiI and NotI, a factor Xa protease cleavage site, and a
glycine-glycine-glycine-glycine-serine (G4S) linker. The
plasmid FCXL(A) is derived from retroviral vector
FXL(A) and contains an additional anti-carcinoembryonic
antigen (CEA) single-chain antibody (scFv) between the SfiI
and NotI restriction enzyme sites. The FXL(A) and
FCXL(A) plasmids have been described in the accompa-
nying article. For library construction, the unique KpnI-NotI
restriction fragment of FXL(A) was subcloned into the
KS() plasmid (Stratagene, La Jolla, CA) at the same
restriction sites. The 24-nucleotide sequence encoding the
FLAG epitope was randomized by PCR: the 5-PCR primer
5-ATAAGGTTATTTGGGTACCCTCTCGGAAAGTTA-
AACCGG AT-3 and a 3-PCR primer pool was synthesized
5-AATGGCGGCCGCGGCCGGCTGGGCC GCNNNNN-
NNN NNNNNNNNNNNNNNNNAG CTCTTACCCCCG-
TAA-3, where N denotes all four A, T, C, and G nucleo-
tides. The nucleotide primers were synthesized by the Mayo
Clinic Molecular Biology Core using a PE Applied Biosys-
Fig. 2. The frequency of each amino acid at each position in the 8-mer peptide encoded in the plasmid library and the virus library. The nucleotide sequence
was determined from representatives of the plasmid library directly (176 different colonies), and the virus library after amplification of the region by RT-PCR
and subcloning (54 colonies). Tryptophan (W) was not encoded in the peptides of the sequenced representatives of the virus library (*);however, tryptophan
was represented in other viruses (see Fig. 3). The frequency profiles of the plasmid and virus libraries do not reflect the theoretical expected amino acid
frequencies due to the differential degradation of the stock nucleotides used to synthesize the randomized PCR primers.
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Fig. 3. Peptides selected by different immobilized monoclonal antibodies from the ALV 8-mer peptide display library. Aliquots of the ALV 8-mer peptide
display library were spiked with 1.0% FXL(A) virus and selected in plates coated with a monoclonal antibody: either against the FLAG epitope (Anti-Flag
mAb), a influenza A hemaglutinnin epitope (Anti-HA mAb), or a vesicular stomatitis virus (VSV) glycoprotein epitope (Anti-VSV Glycoprotein mAb). The
unbound viruses were removed by extensive washing, and the bound viruses were recovered by adding DF-1 cells to allow viral infection and amplification.
The amplified pools of bound viruses were again selected as above for two more rounds. The genomic RNAs of bound virus pool from each round were
amplified by RT-PCR and cloned and the nucleotide sequence was determined encoding the displayed peptide. Peptide sequences common to different rounds
of selection are highlighted in different shades of gray.
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tems 3948 Nucleic Acid Synthesis and Purification System.
The 294-bp PCR product was digested with KpnI-NotI; the
digested fragment was purified (2 g) and ligated with 18
g of KpnI-NotI-digested FCXL(A) plasmid in a 200-l
reaction containing 4  104 U T4 ligase (New England
Biolabs, Beverly, MA) at 16°C for 14 h. The ligation reac-
tion was purified by phenol:chloroform extraction and eth-
anol precipitation and resuspended in 50 l 10 mM Tris, pH
8.0. Highly competent E. coli DH10B cells (400 l)
(GIBCO/BRL) were mixed with 5 l purified ligation prod-
uct for each electroporation (10 reactions total) in 0.2-cm
cuvettes (Bio-Rad, Hercules, CA) pulsed with a time con-
stant of 4.64 ms at 2.5 kV, 200 , and 25 F (Bio-Rad).
Aliquots of the electroporated cells were plated onto ampi-
cillin-containing NZY plates. Plasmid DNA was purified
using Qiagen Plasmid Maxi Kits (Qiagen Inc., Valencia,
CA).
Cell culture and virus propagation
DF-1 cells, a chicken fibroblast cell line (Himly et al.,
1998; Schaefer-Klein et al., 1998), were grown in Dulbec-
co’s modified Eagle’s medium (GIBCO/BRL) supple-
mented with 10% fetal bovine serum (GIBCO/BRL), 100 U
of penicillin per ml, and 100 g of streptomycin per milli-
liter (Quality Biological, Inc., Gaithersburg, MD) at 39°C
and 5% CO2. Virus propagation was initiated either by
transfection of plasmid DNA that contained the retroviral
vector (with wild-type or chimeric env genes) in proviral
form (Federspiel and Hughes, 1997) or by direct infection.
Virus stocks were generated from cell-culture supernatants.
The supernatants were cleared of cellular debris by centrif-
ugation at 2000 g for 10 min at 4°C and stored in aliquots
at 80°C. Virus titers were determined by mixing 10-fold
serial dilutions of the virus stock with DF-1 cells and as-
saying for AP activity 48 h later as described previously
(Holmen et al., 1999).
Generation of retrovirus peptide display library
To generate the ALV 8-mer virus library, 9  106 DF-1
cells were transfected with 30 g plasmid DNA purified
from the plasmid library using Superfect transfection re-
agent (Qiagen). Two days after transfection the supernatant
was collected (30 ml); fresh 10% DMEM was added to cells
and incubated for 12 h and the supernatant was collected
and combined with day 2 (60 ml total). To deconvolute the
unlinked virus library, fresh DF-1 cells (4  107) infected
with the unlinked virus library at a 0.1 m.o.i in two cell
factory-2 (Nunc, Naperville, IL). The cells were split into
one cell factory-10 (Nunc) when the cells were confluent (3
days) and incubated for an additional 3 days. The superna-
tant was collected (1000 ml), cleared, and frozen in aliquots
and constitutes the ALV 8-mer peptide display library.
ALV display library selection procedure
The selection procedure was a modification of the IRISA
assay published previously (Russell et al., 1993 and the
accompanying article). Briefly, six-well plates (Costar,
Corning, NY) were coated with anti-Flag mAb (Sigma, St.
Louis, MO), anti-HA mAb (Sigma), or anti-VSV-G mAb
(Sigma) (12.5 g/ml) in 2 ml/well coating buffer (0.015 M
of Na2CO3; 0.035 M of NaHCO3) for 2 h at 4°C. The plates
were then washed three times with PBS (2 ml/well) and
nonspecific protein binding blocked with 5% bovine serum
albumin for 1 h at 37°C followed by DMEM containing
10% fetal calf serum for 1 h at 37°C. Plates were washed
three times with PBS and incubated with ALV virus stock
(2 ml/well) for 2 h at 4°C. The plates were then washed with
PBS three times followed by PBS with 0.1% Tween 80 four
times. To recover and amplify the bound viruses, fresh DF-1
cells were added and the cultures were incubated for 2 days
to allow virus infection and spread. The supernatants were
collected, cleared, and frozen in aliquots and constituted the
selected virus from that round of screening. The process was
repeated for each round of selection. Virus titers were quan-
titated by AP assay.
Nucleotide sequence analysis
Plasmid DNA was isolated from individual colonies
from the ALV 8-mer plasmid library using Qiagen Plasmid
Mini Kit to determine the nucleotide sequence. Viral RNA
was isolated from the aliquots of ALV 8-mer peptide dis-
play virus library using RNA Isolation Kit (Qiagen). RT-
PCR was performed using a Titan one tube RT-PCR kit
(Roche, Indianapolis, IN) using forward primer Env Seq. 1
5-GGTCTGGGGACGAGGTT ATGC-3 [complementary
to nucleotides 8460–8480 of the RCASBP(A) molecular
clone] and Reverse-X primer 5-CCGTTTGGCCTGTACG-
GTTGG-3 [complementary to nucleotides 8814–8834 of
RCASBP(A)]. The RT-PCR product (449 bp) was cloned
into TA-cloning vector (Invitrogen Carlsbad, CA); plasmid
DNA was isolated as above and the nucleotide sequence
was determined. Nucleotide sequences were determined by
the Mayo Clinic Molecular Biology Core on a Perkin–
Elmer ABI PRISM 377 DNA sequencer (with XL upgrade)
with PE Applied Biosystems ABI PRISM dRhodamine Ter-
minator Cycle Sequencing Ready Reaction Kit and Ampli-
Taq DNA Polymerase (PE Applied Biosystems, Foster City,
CA).
Statistical analysis
Four major sets of statistical analyses were performed to
determine if the displayed plasmid sequences behaved as if
generated from a random stochastic process in which suc-
cessive nucleotides are selected randomly and indepen-
dently. The analyses were (1a) a comparison of the overall
observed distribution of amino acids to the expected distri-
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bution using a 2 test on 20 degrees of freedom; (1b) a
comparison of the overall observed distribution of codons to
the expected distribution using a 2 test on 63 degrees of
freedom; (2) an analysis of independence of nucleotide and
position using 2 test on 69 degrees of freedom for a 24 
4 table; (3) an analysis of serial correlation at a lag of 1
using logistic regression with lagged variables; and (4) an
analysis of clustering of nucleotides within sequence using
alternating logistic regression in PROC GENMOD in SAS.
These analyses were performed both for the plasmid se-
quences and for the virus data.
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